{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:22:47Z","timestamp":1768821767651,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["11010167"],"award-info":[{"award-number":["11010167"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jns.2017.11.014","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:32:23Z","timestamp":1510846343000},"page":"188-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases"],"prefix":"10.1016","volume":"383","author":[{"given":"Wessam E.","family":"Sharaf-Eldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmeen A.","family":"Kishk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehia Z.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-0262","authenticated-orcid":false,"given":"Mohamed A.M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha S.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona L.","family":"Essawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0005","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T."},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2015.06.015","article-title":"Biomarkers in multiple sclerosis","volume":"161","author":"Housley","year":"2015","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WCO.0000000000000455","article-title":"Neuromyelitis optica and neuromyelitis optica spectrum disorders","volume":"30","author":"Marignier","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","article-title":"The immunology of neuromyelitis optica-current knowledge, clinical implications, controversies and future perspectives","volume":"17","author":"Jasiak-Zatonska","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jns.2017.11.014_bb0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jns.2017.11.014_bb0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jns.2017.11.014_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"9","key":"10.1016\/j.jns.2017.11.014_bb0055","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum microRNAs are promising novel biomarkers","volume":"3","author":"Gilad","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"O'Connell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.jns.2017.11.014_bb0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2017.11.014_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fncel.2013.00150","article-title":"Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies","volume":"7","author":"Sheinerman","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.jns.2017.11.014_bb0075","doi-asserted-by":"crossref","first-page":"e7440","DOI":"10.1371\/journal.pone.0007440","article-title":"Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls","volume":"4","author":"Keller","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jns.2017.11.014_bb0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2017.11.014_bb0085","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/1352458513490542","article-title":"Differential microRNA expression in blood in multiple sclerosis","volume":"19","author":"S\u00f8ndergaard","year":"2013","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.jns.2017.11.014_bb0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ni.1918","article-title":"MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation","volume":"11","author":"Li","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.jns.2017.11.014_bb0100","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."},{"issue":"Pt 12","key":"10.1016\/j.jns.2017.11.014_bb0105","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47","volume":"132","author":"Junker","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2017.11.014_bb0110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21220","article-title":"Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions","volume":"62","author":"Koning","year":"2007","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2017.11.014_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.10.006","article-title":"miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing","volume":"248","author":"Guerau-de-Arellano","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/1744666X.2015.991315","article-title":"Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future","volume":"11","author":"Raphael","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jns.2017.11.014_bb0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2016.00129","article-title":"Is it worth considering circulating microRNAs in multiple sclerosis?","volume":"7","author":"Jagot","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International panel for NMO diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2017.11.014_bb0140","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.jns.2017.11.014_bb0145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2017.11.014_bb0150","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2017.11.014_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.jns.2017.11.014_bb0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nmeth.3485","article-title":"miRWalk2.0: a comprehensive atlas of microRNA-target interactions","volume":"12","author":"Dweep","year":"2015","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.jns.2017.11.014_bb0165","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"10","key":"10.1016\/j.jns.2017.11.014_bb0170","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","article-title":"Contribution of MicroRNAs to autoimmune diseases","volume":"73","author":"Garo","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(11)70286-1","article-title":"Non-coding RNAs with essential roles in neurodegenerative disorders","volume":"11","author":"Salta","year":"2012","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2017.11.014_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4161\/rna.8.4.16029","article-title":"Population differences in microRNA expression and biological implications","volume":"8","author":"Huang","year":"2011","journal-title":"RNA Biol."},{"issue":"14","key":"10.1016\/j.jns.2017.11.014_bb0185","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1177\/1352458513485654","article-title":"Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis","volume":"19","author":"Fenoglio","year":"2013","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.jns.2017.11.014_bb0190","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1007\/s11033-011-1441-7","article-title":"Circulating microRNAs involved in multiple sclerosis","volume":"39","author":"Siegel","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jns.2017.11.014_bb0195","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12974-015-0418-1","article-title":"Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis","volume":"12","author":"Keller","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2249.2012.04676.x","article-title":"Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis","volume":"171","author":"MC","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trsl.2012.04.002","article-title":"Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus","volume":"160","author":"Wang","year":"2012","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.jns.2017.11.014_bb0210","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10753-016-0312-8","article-title":"Negative correlation between miR-326 and Ets-1 in regulatory T cells from new-onset SLE patients","volume":"39","author":"Sun","year":"2016","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.jns.2017.11.014_bb0215","doi-asserted-by":"crossref","first-page":"e0174585","DOI":"10.1371\/journal.pone.0174585","article-title":"MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sj\u00f6gren's syndrome","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2017.11.014_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12060","article-title":"Regulation of immune responses and tolerance: the microRNA perspective","volume":"253","author":"Chen","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jns.2017.11.014_bb0225","doi-asserted-by":"crossref","unstructured":"Wu T, Chen G. miRNAs participate in MS pathological processes and its therapeutic response. Mediat. Inflamm. 2016, 4578230 (2016).","DOI":"10.1155\/2016\/4578230"},{"issue":"9","key":"10.1016\/j.jns.2017.11.014_bb0230","doi-asserted-by":"crossref","first-page":"e24604","DOI":"10.1371\/journal.pone.0024604","article-title":"Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis","volume":"6","author":"Waschbisch","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17344453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17344453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T21:03:24Z","timestamp":1535231004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17344453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":46,"alternative-id":["S0022510X17344453"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.11.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}